Key informants' perceptions of how pharmac operates in New Zealand

International Journal of Technology Assessment in Health Care

Volumn 28, Issue 4, 2012, Pages 367-373

  Ragupathy, Rajan ^a   Tordoff, June ^a   Norris, Pauline ^a   Reith, David ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Healthcare rationing; New Zealand; Pharmaceutical economics; Pharmaceutical policy

Indexed keywords

COMPARISON METHODS; MEMBERS OF PARLIAMENTS; NEW ZEALAND; PHARMACEUTICAL INDUSTRY; POLITICAL STABILITY; POLITICAL SUPPORT; QUALITATIVE ANALYSIS; SEMI STRUCTURED INTERVIEWS;

HEALTH CARE;

MEDICINE;

ARTICLE; DRUG COST; DRUG INDUSTRY; FUNDING; GOVERNMENT; HEALTH CARE ORGANIZATION; HUMAN; NEW ZEALAND; PHARMACEUTICAL MANAGEMENT AGENCY; PUBLIC HEALTH SERVICE; QUALITATIVE ANALYSIS; SEMI STRUCTURED INTERVIEW;

ATTITUDE OF HEALTH PERSONNEL; DRUG INDUSTRY; HEALTH CARE REFORM; HEALTH POLICY; HUMANS; NEW ZEALAND; PERCEPTION; POLITICS;

EID: 84867523128     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462312000566     Document Type: Article

References (27)

1. Aaltonen K, Ragupathy R, Tordoff J, Reith D, Norris P. The impact of pharmaceutical cost containment policies on the range of medicines available and subsidized in Finland and New Zealand. Value Health. 2010;13:148-156.
2. Australian Department of Health and Ageing. National Medicines Policy 2000. http://www.health.gov.au/internet/main/publishing.nsf/Content/ 0241A32640D477CACA256F18004685E4/$File/nmp2000.pdf (accessed April 28, 2012).
3. Begg E, Sidwell A, Gardiner S, Nicholls G, Scott R. The sorry saga of statins in New Zealand-pharmacopolitics versus patient care. N Z Med J. [serial on the Internet] 2003. http://www.nzma.org.nz/journal/116-1170/360/(accessed April 28, 2012).
4. Braae R, McNee W, Moore D. Managing pharmaceutical expenditure while increasing access-the Pharmaceutical Management Agency (PHARMAC) experience. Pharmacoeconomics. 1999;16:649-660.
5. Business and Economic Research Limited (BERL). Independent review of The Castalia Report on New Zealand Pharmaceutical Policies. [Online] 2005. http://www.pharmac.co.nz/2006/05/04/040506b.pdf (accessed April 28, 2012).
6. Castalia Strategic Advisors. New Zealand pharmaceutical policies: Time to take a fresh look. [Online] 2005. http://www.castalia-advisors.com/files/14634. pdf (accessed April 28, 2012).
7. Cumming J, Mays N, Daubé J. Analysis: How New Zealand has contained expenditure on drugs. BMJ. 2010;340:c2441.
8. Davis P. "Tough but fair"? The active management of the New Zealand drug benefits scheme by an independent Crown agency. Aust Health Rev. 2004;28:171-181.
9. Easton B. New Zealand's pharmaceutical policies: A fresh look. [Online] 2005. http://www.pharmac.co.nz/2006/05/04/040506a.pdf (accessed April 28, 2012).
10. Faunce T, Bai J, Nguyen D. Impact of the Australia-US free trade agreement on Australian medicines regulation and orices. J Generic Med. 2010;7:18-19.
11. Isaacs RJ, Frampton CM, Kuper-Hommel MJ. PHARMAC's funding of 9 weeks Herceptin: Many assumptions in a high-risk decision. N Z Med J. [serial on the Internet] 2007. http://www.nzma.org.nz/journal/120-1259/2676/(accessed April 28, 2012).
12. Lancet Editorial. New 50 million cancer fund already intellectually bankrupt. Lancet. 2010;376:389.
13. Lee TH, Emanuel EJ. Tier 4 drugs and the fraying of the social compact. N Engl J Med. 2008;359:333-335.
14. McCormack P, Quigley J, Hansen P. Report to Minister of Health, Hon Tony Ryall-Review of access to high cost, highly specialised medicines in New Zealand. [Online]. http://img.scoop.co.nz/media/pdfs/1005/Review-of-Access-to- High-Cost-Highly-Specialised-Medicines-31-April-2010.pdf (accessed April 28, 2012).
15. Metcalfe S, Rodgers A, Werner R, Schousboe C. PHARMAC has no cost-effectiveness threshold. N Z Med J. [serial on the Internet] 2012. http://journal.nzma.org.nz/journal/125-1350/5083/(accessed April 28, 2012).
16. Moodie P, Metcalfe S, McNee W. Response from PHARMAC: Difficult choices. NZ Med J. [serial on the Internet] 2003. http://www.nzma. org.nz/journal/116- 1170/361/(accessed April 28, 2012).
17. Moodie P, Metcalfe S, Poynton M. Do pharmaceutical score cards give us the answers we seek? NZ Med J. [serial on the Internet] 2011. http://journal.nzma.org.nz/journal/124-1346/4976/(accessed April 28, 2012).
18. Moynihan R. New Zealand agency comes under pressure to pay more for drugs. BMJ. 2011;342 doi:10.1136/bmj.d3933.
19. New Zealand Ministry of Health. Medicines New Zealand. [Online]. http://www.health.govt.nz/publication/medicines-new-zealand (accessed April 28, 2012).
20. New Zealand Parliament. New Zealand Public Health And Disability Act 2000 [Online] 2000. http://www.legislation.govt.nz/(accessed April 28, 2012).
21. New Zealand Pharmaceutical Industry Taskforce. Submission on the Towards a New Zealand Medicines Strategy consultation document. Wellington: New Zealand Pharmaceutical Industry Taskforce; 2007.
22. Pearson SD, Rawlins MD. Quality, innovation and value for money: NICE and the British National Health Service. JAMA. 2005;294:2618-2622.
23. Ragupathy R, Aaltonen K, Tordoff J, Norris P, Reith D. A 3-dimensional view of access to licensed and subsidized medicines under single payer systems in the United States, United Kingdom, Australia and New Zealand. Pharmacoeconomics (in press). 2011.
24. Ryall T. Government extends Pharmac role. [Online]. http://www.beehive. govt.nz/release/government-extends-pharmac-role (accessed April 28, 2012).
25. Taylor L. Australian govt blocks subsidies of new drugs. PharmaTimes Online [serial on the Internet]. 2011. http://www.pharmatimes.com/Article/11-03- 15/Australian-govt-blocks-subsidies-for-new-drugs.aspx (accessed April 28, 2012).
26. The United Kingdom Department of Health. The Pharmaceutical Price Regulation Scheme 2009. [Online]. http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-091825 (accessed April 28, 2012).
27. Wonder M, Milne R. Access to new medicines in New Zealand compared to Australia. NZ Med J. [serial on the Internet] 2011. http://journal. nzma.org.nz/journal/124-1346/4966/(accessed April 28, 2012).